← Open Payments lookup

AMELIA MANGUNE: Open Payments

NPI 1316656473 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,512 in 56 payments from 11 companies in 2025. Trend: 2023 $841 · 2024 $646 · 2025 $1,512

Food & beverage: $1,412Education: $100
CompanyPaymentsAmount
Janssen Biotech, Inc.13$518
ABBVIE INC.29$498
GENZYME CORPORATION2$141
Phathom Pharmaceuticals, Inc.3$134
QOL Medical, LLC3$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$30
Ipsen Biopharmaceuticals, Inc1$25
Aimmune Therapeutics, Inc.1$25
Takeda Pharmaceuticals U.S.A., Inc.1$22
Madrigal Pharmaceuticals1$19

Products named: TREMFYA, RINVOQ, DUPIXENT, VOQUEZNA, SKYRIZI, MAVYRET, Sucraid, CREON.

Industry payments across NV — which companies pay providers there.